StockData
BeOne Medicines Ltd. logo

BeOne Medicines Ltd.

ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$361.27−9.06 (-2.45%)

Close on Nov 2, 2026Market cap $41.08BP/E 64.6Yield –

BeOne Medicines Share Options Outstanding at Year-End by Year

Share Options Outstanding at Year-End (M options) (M)

BeOne Medicines Share Options Outstanding at Year-End: 48.2M in FY2025, down 38.2% from a year earlier. That is the lowest of the 8 years on record here.

Latest, FY2025
48.2
Period ended Dec 31, 2025
Change on a year earlier
-38.2%
78.0 in FY2024
History
8 years
Since FY2018
Sources
5
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (filed 2026-02-26) ↗

Reported in Form 10-K Share-Based Compensation Note (XBRL).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedShare Options Outstanding at Year-End (M options) (M)Year on yearSource
FY2025Dec 31, 202548.2-38.2%Form 10-K (filed 2026-02-26) ↗
FY2024Dec 31, 202478.0-0.2%Form 10-K (filed 2026-02-26) ↗
FY2023Dec 31, 202378.1+2.1%Form 10-K (filed 2025-02-27) ↗
FY2022Dec 31, 202276.5+6.0%Form 10-K (filed 2025-02-27) ↗
FY2021Dec 31, 202172.2-15.0%Form 10-K (filed 2025-02-27) ↗
FY2020Dec 31, 202085.0-21.6%Form 10-K (filed 2024-02-26) ↗
FY2019Dec 31, 2019108-6.6%Form 10-K (filed 2023-02-27) ↗
FY2018Dec 31, 2018116–Form 10-K (filed 2022-02-28) ↗

Cite this data

StockData. (2026). BeOne Medicines Share Options Outstanding at Year-End (M), annual FY2018–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/opt-out-sh

See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.